Baxter International (BAX) Tops Q2 EPS by 5c; Guides Q3, Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts BAX Hot Sheet
Price: $39.52 --0%
EPS Growth %: +3.4%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: +3.4%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Baxter International, Inc. (NYSE: BAX) reported Q2 EPS of $1.07, $0.05 better than the analyst estimate of $1.02. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.38 billion.
Sees Q3 2011 EPS of $1.07-$1.09, versus the consensus of $1.07.
Sees FY2011 EPS of $4.27-$4.32, versus prior guidance of $4.20-$4.28 and the consensus of $4.26.
Sees Q3 2011 EPS of $1.07-$1.09, versus the consensus of $1.07.
Sees FY2011 EPS of $4.27-$4.32, versus prior guidance of $4.20-$4.28 and the consensus of $4.26.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- Kinder Morgan (KMI) Misses Q1 EPS by 1c
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
